Drug and Alcohol Screening Market - Forecasts from 2019 to 2024

Drug and Alcohol Screening Market - Forecasts from 2019 to 2024

Drug and alcohol screening test mainly analyzes biological samples such as urine, blood and hair to diagnose the presence of drug. The rise in alcohol consumption, overuse of prescribed drugs, the rise in usage of narcotics and illicit drugs are driving the global drug and alcohol screening market. The drug and alcohol screening market is expected to reach US$XX.XX billion in 2024 from US$XX.XX billion in 2018 with CAGR of XX.XX%.

The enforcement of strict laws and regulation in various countries and financial support from government are the key growth factors of drug and alcohol screening market. Rise in alcohol and drug abuse, growing knowledge and awareness among developing countries, growing ageing population and competition among leading manufacturers in drug and alcohol screening market for innovative products are the reason for the increasing demand for drug and alcohol screening. Technological advancement are expected to boost the market over the world for the forcasted period. The ban on alcohol and drug consumption in some countries and accuracy issues in testing instruments are hindering the growth of the market in the coming years.

In terms of region, global drug and alcohol screening market has been classified into North America, South America, Middle East and Africa, Europe and Asia-Pacific. Government policies towards drug usage are helping to grow more in North America. Asia-Pacific region is going to be new hub for exporting dug screening instruments. Companies like, Alere Inc has started it’s operation in India in 2016.

Key players operating in global drug and alcohol screening market are Abbott Laboratories, Thermo Fisher Scientific, Alere Inc, Quest Diagnostics, and OraSure Technologies, among others.

Segmentation

The drug and alcohol screening market has been analyzed through the following segments:

By Sample Type

Urine

Breath

Oral Fluid

Blood

Others

 

By End-User

Hospitals and Treatment Facilities

Law and Enforcement

Sporting Events

Others

 

By Geography

North America

United States of America

Canada

Mexico

Others

 

South America

Brazil

Argentina

Others

 

Europe

United Kingdom

Germany

France

Italy

Others

 

Middle East and Africa

United Arab Emirates

Israel

Saudi Arabia

Others

 

Asia Pacific

China

Japan

India

South Korea

Others

 

Target Audience

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants

 

Key insights offered

What will be the drug and alcohol screening market size from 2019 to 2025?

How are the major drivers and restraints affecting the global drug and alcohol screening market?

The Drug and alcohol screening market growth and the opportunities which exist for key vendors?

Which segment and region will lead the global drug and alcohol screening market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour in the drug and alcohol screening market .

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth for the drug and alcohol screening market.

1. INTRODUCTION
1.1. MARKET OVERVIEW
1.2. MARKET DEFINITION
1.3. SCOPE OF THE STUDY
1.4. CURRENCY
1.5. ASSUMPTIONS
1.6. BASE, AND FORECAST YEARS TIMELINE
2. RESEARCH METHODOLOGY  
2.1. RESEARCH DESIGN
2.2. SECONDARY SOURCES
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. MARKET SEGMENTATION
4.2. MARKET DRIVERS
4.3. MARKET RESTRAINTS
4.4. MARKET OPPORTUNITIES
4.5. PORTER’S FIVE FORCE ANALYSIS
4.5.1. BARGAINING POWER OF SUPPLIERS
4.5.2. BARGAINING POWER OF BUYERS
4.5.3. THREAT OF NEW ENTRANTS
4.5.4. THREAT OF SUBSTITUTES
4.5.5. COMPETITIVE RIVALRY IN THE INDUSTRY
4.6. LIFE CYCLE ANALYSIS - REGIONAL SNAPSHOT
4.7. MARKET ATTRACTIVENESS
5. DRUG AND ALCOHOL SCREENING MARKET BY SAMPLE TYPE
5.1. URINE
5.2. BREATH
5.3. ORAL FLUID
5.4. BLOOD
5.5. OTHERS
6. DRUG AND ALCOHOL SCREENING MARKET BY END-USER 
6.1. HOSPITALS AND TREATMENT FACILITIES
6.2. LAW AND ENFORCEMENT
6.3. SPORTING EVENTS
6.4. OTHERS
7. DRUG AND ALCOHOL SCREENING MARKET BY GEOGRAPHY
7.1. NORTH AMERICA
7.1.1. USA
7.1.2. CANADA
7.1.3. MEXICO
7.1.4. OTHERS
7.2. SOUTH AMERICA
7.2.1. BRAZIL
7.2.2. ARGENTINA
7.2.3. OTHERS
7.3. EUROPE
7.3.1. UNITED KINGDOM
7.3.2. GERMANY
7.3.3. FRANCE
7.3.4. ITALY
7.3.5. OTHERS
7.4. MIDDLE EAST AND AFRICA
7.4.1. UNITED ARAB EMIRATES
7.4.2. ISRAEL
7.4.3. SAUDI ARABIA
7.4.4. OTHERS
7.5. ASIA PACIFIC
7.5.1. CHINA
7.5.2. JAPAN
7.5.3. INDIA
7.5.4. SOUTH KOREA
7.5.5. OTHERS
8. COMPETITIVE INTELLIGENCE
8.1.  COMPETITIVE BENCHMARKING AND ANALYSIS
8.2.  RECENT INVESTMENT AND DEALS
8.3. STRATEGIES OF KEY PLAYERS
9. COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.2. THERMO FISHER SCIENTIFIC
9.3. QUEST DIAGNOSTICS
9.4. ORASURE TECHNOLOGIES
9.5. OMEGA LABORATORIES LTD
9.6. SUREHIRE
9.7. EXPRESS DIAGNOSTICS INTERNATIONAL INC.
9.8. ROCHE DIAGNOSTICS
9.9. MPD INC.
9.10. SIEMENS HEALTHINEERS
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER 

Abbott Laboratories

Thermo Fisher Scientific

Quest Diagnostics

OraSure Technologies

Omega Laboratories Ltd

SureHire

Express Diagnostics International Inc.

Roche Diagnostics

MPD Inc.

Siemens Healthineers

  • SKU:
  • Publishing Date: 2019-03-14
  • Product Code: 1
  • Availability: In Stock
  • $3,950.00
  • Ex Tax: $3,950.00

Available Options